The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Set To Follow US And Asian Stocks Lower

Wed, 12th Mar 2014 07:38

LONDON (Alliance News) - UK stocks are set to open lower Wednesday, following on from weak sessions in the US and Asia, as investors continue to be starved of significant fresh data releases.

Meanwhile, a host of FTSE 100-listed companies have gone ex-dividend which is set to further weigh on the UK's blue-chip index Wednesday.

"Are investors starting to exhibit the first signs of concern that maybe the run higher in US equity markets and broader markets has run its course?" asks Michael Hewson, chief market analyst at CMC Markets.

The ongoing crisis in Ukraine and continued fears about a slowdown in China's economy continue to weigh heavy on investors shoulders.

Wall Street closed firmly lower on Tuesday, with the DJIA, NASDAQ Composite and S&P 500 down between 0.4 % and 0.5%.

Asian stocks have followed suit, with the Hang Seng and Shanghai Composite index trading down 1.6% and 0.2% prior to the UK equity market open. The Nikkei in Tokyo closed down 2.6% after the Japanese Cabinet Office revealed that confidence among Japanese households deteriorated for the third consecutive month in February.

The headline consumer confidence index dropped sharply to 38.2 in February from the downwardly revised 40.4 in January, missing expectations of a more modest decline to 40 from the originally reported 40.5.

In London, the FTSE 100 is indicated to open firmly lower by CMC Markets and IG, having closed at 6,685.52 on Tuesday. CMC Markets expects the index to open down at approximately 6,643 points, while IG indicates an even-lower opening level of 6,635.

In a light data calendar Wednesday, early focus will be on industrial production figures for the euro area at 1000 GMT.

Eurozone industrial production is expected to report a rise of 0.5% month-on-month in January, rebounding from a 0.7% decline in December. On a yearly basis, industrial production is forecast to rise by 1.9%, up from the 0.5% recorded in December.

"While this morning?s data is expected to point to continued modest recovery in the euro area, it is unlikely to make an impact on monetary policy expectations given European Central Bank President Draghi?s comments last week that monetary policy in the euro area will remain unchanged over the near term," says Carl Paraskevas, senior international macroeconomist at Lloyds Bank.

Also in the data calendar, US MBA mortgage applications information for the week ended March 7 is released at 1100 GMT. US Treasury Secretary Jack Lew gives a speech at 1800 GMT. There is no significant UK data scheduled.

In corporate news, FTSE 250-listed Ferrexpo and Hikma Pharmaceuticals, amongst others, have released full-year results for 2013 Wednesday. Ocado Group has released an interim management statement. Prudential is scheduled to release its full-year 2013 results at approximately 0815 GMT.

Pets at Home and Poundland will become the third and fourth British retailers to list in 2014 when conditional dealings start Wednesday.

Meanwhile, a large number of blue-chip companies have gone ex-dividend Wednesday, meaning that new buyers no longer qualify for the latest dividend payout from the company. The list includes HSBC, Standard Chartered, British American Tobacco, Meggitt, Randgold Resources, Land Securities, Hammerson, and Hargreaves Lansdown.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.